中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Synthesis and anti-tumor activities of methyl 2-O-aryl-6-O-aryl '-D-glucopyranosides

文献类型:期刊论文

作者Shi HF(史合方) ; Zhou BC(周炳成) ; Li WW(李雯雯) ; Shi ZM(石志敏) ; Yu B(俞飚) ; Wang RX(王任小)
刊名Bioorg. Med. Chem. Lett.
出版日期2010
卷号20期号:9页码:2855-2858
ISSN号0960-894X
其他题名具有抗癌活性的化合物甲基-2-氧-芳基-6-氧-芳基-D-Glucopyranosides的合成
通讯作者俞飚 ; 王任小
英文摘要A synthetic method of introducing bulky aryl groups at the 2-O- and 6-O-positions on glucopyranosides was developed. A total of 37 new compounds of this class were obtained successfully. These compounds were tested on several tumor cell lines by MTT assays, and some of them exhibited encouraging inhibitory activities. The most potent compound, CAB-SHZH-27, exhibited EC50 values of 14, 12, and 10 mu mol/L on A549, MDA-MB-231 and HeLa cells, respectively. A preliminary structure-activity relationship analysis indicates that the two free hydroxyl groups on the D-glucose core are indispensable for the biological activities of this class of compounds, and the aryl group at the 6-O-position has a more obvious impact than the one at the 2-O-position. An interesting 'on-off' mechanism of this class of compounds was also observed in our MTT assays, which remains to be explored. (C) 2010 Elsevier Ltd. All rights reserved.
学科主题生命有机化学
收录类别SCI
原文出处http://dx.doi.org/10.1016/j.bmcl.2010.03.045
语种英语
WOS记录号WOS:000276816600034
公开日期2013-02-25
源URL[http://202.127.28.38/handle/331003/19123]  
专题上海有机化学研究所_生命有机化学国家重点实验室
推荐引用方式
GB/T 7714
Shi HF,Zhou BC,Li WW,et al. Synthesis and anti-tumor activities of methyl 2-O-aryl-6-O-aryl '-D-glucopyranosides[J]. Bioorg. Med. Chem. Lett.,2010,20(9):2855-2858.
APA 史合方,周炳成,李雯雯,石志敏,俞飚,&王任小.(2010).Synthesis and anti-tumor activities of methyl 2-O-aryl-6-O-aryl '-D-glucopyranosides.Bioorg. Med. Chem. Lett.,20(9),2855-2858.
MLA 史合方,et al."Synthesis and anti-tumor activities of methyl 2-O-aryl-6-O-aryl '-D-glucopyranosides".Bioorg. Med. Chem. Lett. 20.9(2010):2855-2858.

入库方式: OAI收割

来源:上海有机化学研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。